WallStreetZenWallStreetZen

NASDAQ: AMLX
Amylyx Pharmaceuticals Inc Stock Ownership - Who owns Amylyx Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Amylyx Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Joshua B. CohenCo-Chief Executive Officer2026-03-0229,282$14.48
$424.12kSell
Gina MazzarielloChief Legal Officer2026-03-026,844$14.52
$99.38kSell
Camille L. BedrosianChief Medical Officer2026-03-026,461$14.58
$94.21kSell
Justin B. KleeCo-Chief Executive Officer2026-03-0229,282$14.47
$423.77kSell
James M. FratesChief Financial Officer2026-03-027,909$14.52
$114.85kSell
Gina MazzarielloChief Legal Officer2026-02-233,419$14.14
$48.35kSell
James M. FratesChief Financial Officer2026-02-023,557$14.65
$52.10kSell
Joshua B. CohenCo-Chief Executive Officer2026-02-0215,500$14.68
$227.59kSell
Justin B. KleeCo-Chief Executive Officer2026-02-0215,500$14.69
$227.62kSell
Gina MazzarielloChief Legal Officer2026-02-023,448$14.65
$50.52kSell

1 of 4

AMLX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AMLX insiders and whales buy or sell their stock.

AMLX Shareholders

What type of owners hold Amylyx Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Morningside Venture Investments Ltd23.60%26,091,760$360.33MInsider
Fmr LLC14.94%16,518,419$228.12MInstitution
Isaac Cheng9.43%10,422,228$143.93MInsider
Blackrock Inc8.19%9,054,431$125.04MInstitution
Perceptive Advisors LLC7.50%8,284,882$114.41MInstitution
Tcg Crossover Management LLC5.65%6,243,812$86.23MInstitution
Invest 1. Bv Als5.33%5,895,280$81.41MInsider
Vanguard Group Inc5.25%5,804,912$80.17MInstitution
Commodore Capital LP5.11%5,650,000$78.03MInstitution
Saturn V Capital Management LP4.07%4,496,487$62.10MInstitution

1 of 3

AMLX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AMLX66.79%33.21%Net SellingNet Selling
IOVA19.44%80.56%Net SellingNet Selling
NRIX93.03%6.97%Net SellingNet Selling
NUVB57.01%42.99%Net Buying
NBTX11.82%0.00%
View Top Biotech Stocks

Amylyx Pharmaceuticals Stock Ownership FAQ

Who owns Amylyx Pharmaceuticals?

Amylyx Pharmaceuticals (NASDAQ: AMLX) is owned by 101.61% institutional shareholders, 50.53% Amylyx Pharmaceuticals insiders, and 0.00% retail investors. Morningside Venture Investments Ltd is the largest individual Amylyx Pharmaceuticals shareholder, owning 26.09M shares representing 23.60% of the company. Morningside Venture Investments Ltd's Amylyx Pharmaceuticals shares are currently valued at $353.02M.

If you're new to stock investing, here's how to buy Amylyx Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.